High-throughput neutralisation tests could lead to a better understanding of the evolution of human influenza.
Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an innovative antibody platform aimed at tackling one of the greatest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results